A synergistic chemodynamic-photodynamic-photothermal therapy platform based on biodegradable Ce-doped MoO nanoparticles

Near-infrared light-induced catalysts are considered to be potential nanoagents for tumor therapy. Cerium (Ce) is a non-biotoxic lanthanide element and exhibits variable valence states for catalytic reactions. In this work, we report a one-step hydrothermal synthesis for Ce-doped MoO x (CMO) nanomat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanoscale 2022-10, Vol.14 (39), p.14471-14481
Hauptverfasser: Li, Danyang, Ha, Enna, Zhang, Jingge, Wang, Luyang, Hu, Junqing
Format: Artikel
Sprache:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Near-infrared light-induced catalysts are considered to be potential nanoagents for tumor therapy. Cerium (Ce) is a non-biotoxic lanthanide element and exhibits variable valence states for catalytic reactions. In this work, we report a one-step hydrothermal synthesis for Ce-doped MoO x (CMO) nanomaterials. The obtained CMO nanomaterials show high absorption in the NIR II regime and a high photothermal conversion efficiency of 67.7% (1064 nm). Moreover, due to the doping of Ce element, the consumption of hydrogen peroxide (H 2 O 2 ) and glutathione (GSH) is boosted which enhances the chemodynamic and photodynamic therapy simultaneously. Under NIR II laser irradiation, the designed CMO nanocatalysts induce metabolism disruption and mitochondrial damage in the tumor cells. As-prepared CMO nanomaterials also show good biocompatibility and pH-responsive degradation behavior, which can be degraded rapidly under alkaline conditions (pH = 7.4) and remain stable in acidic solution (pH = 5.6). These properties make CMO nanomaterials ideal biodegradable nanotheranostic agents for synergistic chemodynamic-photodynamic-photothermal antitumor therapy. Biodegradable Ce-doped MoO x nanoparticles were designed for tumor CDT/PDT/PTT synergistic therapy in the NIR-II biowindow.
ISSN:2040-3364
2040-3372
DOI:10.1039/d2nr03479d